The larger populations of CD4+ cells and CD8+ cells and increased serum levels of sPD-L1 in patients’ peripheral blood with GHPA suggest that the tumor not only affects the TIME but also profoundly exerts systemic effects involving immunity. This evidence concerns the gene CD4 and neoplasm.